BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27647437)

  • 1. A long non-coding RNA signature to improve prognosis prediction of gastric cancer.
    Zhu X; Tian X; Yu C; Shen C; Yan T; Hong J; Wang Z; Fang JY; Chen H
    Mol Cancer; 2016 Sep; 15(1):60. PubMed ID: 27647437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-lncRNA expression signature associated with the prognosis of gastric cancer patients.
    Song P; Jiang B; Liu Z; Ding J; Liu S; Guan W
    Cancer Med; 2017 Jun; 6(6):1154-1164. PubMed ID: 28444881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
    Hu Y; Chen HY; Yu CY; Xu J; Wang JL; Qian J; Zhang X; Fang JY
    Oncotarget; 2014 Apr; 5(8):2230-42. PubMed ID: 24809982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
    Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
    J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
    Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
    Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.
    Ren W; Zhang J; Li W; Li Z; Hu S; Suo J; Ying X
    Med Sci Monit; 2016 Oct; 22():3647-3657. PubMed ID: 27727196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
    Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H
    Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
    Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C
    Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A four-long non-coding RNA signature in predicting breast cancer survival.
    Meng J; Li P; Zhang Q; Yang Z; Fu S
    J Exp Clin Cancer Res; 2014 Oct; 33(1):84. PubMed ID: 25288503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.